P&G Buys Vitamin Brand Thorne for $3.8 Billion
Consumer goods giant Procter & Gamble is acquiring supplements brand Thorne to grow its health business and reach younger shoppers.
Procter & Gamble (P&G), one of the world's biggest consumer goods companies, is buying vitamin and supplement brand Thorne for $3.8 billion. P&G makes everyday products you probably use — like Oral-B toothbrushes and Vicks cough medicine.
The deal is an acquisition (when one company buys another and takes control of it). P&G wants to grow its health and wellness division, which sells things people take to feel better.
Who is Thorne?
- Founded in 1984, Thorne sells vitamins and supplements.
- It went public (started selling shares of the company on the stock market) in late 2021, valued at $525 million.
- In 2023, an investment firm called L Catterton took it private again (bought all the shares so it's no longer on the stock market) for $680 million.
- In 2025, its yearly revenue (total money earned from sales) passed $500 million.
The bigger picture: Vitamins and supplements have become very popular as people try to improve their sleep, energy, and overall health. The "Make America Healthy Again" movement, led by health official Robert F. Kennedy Jr., has helped fuel this trend. P&G is not alone — earlier this year, rival Unilever bought gummy supplement brand Grüns.
Why P&G needs this: In its most recent quarter (a 3-month reporting period), P&G's sales volume was flat, meaning it didn't sell more products than before. Its health care segment was actually its weakest performer, so buying a growing brand like Thorne could help.
In short: P&G is spending big to grab a piece of the booming vitamin market and win over younger customers. P&G's shares (small pieces of ownership in the company) rose slightly less than 1% in early Tuesday trading.
This is an AI-generated summary. Read the original article at: https://www.cnbc.com/2026/08/04/procter-gamble-will-acquire-supplements-brand-thorne.html